Article

Specific KIR-HLA genotypes predict outcomes of refractory or recurrent primary central nervous system lymphoma

2022-05-10

Abstract excerpt

<h4>Purpose: </h4> An effective salvage regimen for re-induction of remission is lacking for refractory or recurrent primary central nervous system lymphoma (r/r PCNSL). This study aimed to evaluate the efficacy and safety of high dose cytarabine plus temozolomide in treating r/r PCNSL and explore the prognostic factors Methods A single-center retrospective cohort study was conducted to access the efficacy and sa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4cf0cf1a-9edb-5a4f-8bc3-7110a0619159
DOI: 10.21203/rs.3.rs-1621534/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Specific KIR-HLA genotypes predict outcomes of refractory or recurrent primary central nervous system lymphomaDOI 10.21203/rs.3.rs-1621534/v1Read

Specific KIR-HLA genotypes predict the outcomes of refractory or recurrent primary central nervous system lymphomaSemantic proximity Read

Specific KIR-HLA genotypes predict outcomes in refractory or relapsed primary central nervous system lymphoma.Semantic proximity Read

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in TreatmentSemantic proximity Read

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.Semantic proximity Read

Efficacy of BTK inhibitor administered for central high-risk systemic diffuse large B cell lymphoma and primary central nervous system lymphoma: A single-center retrospective studySemantic proximity Read

Allogeneic HSCT Improves Prognosis in Advanced Extranodal NK/T-Cell LymphomaSemantic proximity Read

Primary Central Nervous System Lymphoma: Evolving Biologic Insights and Recent Therapeutic Advances.Semantic proximity Read

Patient's HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma.Semantic proximity Read

Analysis of high-risk factors and prognosis of early relapse in 104 patients with natural killer/T-cell lymphoma: a single-center retrospective studySemantic proximity Read

CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.Semantic proximity Read

Combination chemotherapy consisting of irinotecan, etoposide, and carboplatin (IREC) for refractory or relapsed neuroblastomaSemantic proximity Read

CD19-directed CAR T-cell therapy for treatment of primary CNS lymphomaSemantic proximity Read